Recent trends in lung cancer and its association with COPD: An analysis using the UK GP research database

Primary Care Respiratory Journal

Volumn 19, Issue 1, 2010, Pages 57-61

  Kiri, Victor A ^a   Soriano, Joan B ^b   Visick, George ^c   Fabbri, Leonardo M ^d  

^a PAREXEL INTERNATIONAL   (United States)

^b Program of Epidemiology and Clinical Research CIMERA   (Spain)

^c GLAXOSMITHKLINE   (United Kingdom)

^d UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

Author keywords

COPD; Epidemiology; Lung cancer; Observational; Quantitative

Indexed keywords

ADULT; AGED; ARTICLE; CANCER INCIDENCE; CANCER MORTALITY; CANCER PATIENT; CANCER SURVIVAL; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GENERAL PRACTICE; HUMAN; KNOWLEDGE BASE; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; PRIMARY MEDICAL CARE; SEX DIFFERENCE; UNITED KINGDOM;

AGE DISTRIBUTION; AGED; COHORT STUDIES; DATABASES, FACTUAL; FAMILY PRACTICE; FEMALE; GREAT BRITAIN; HUMANS; INCIDENCE; LUNG NEOPLASMS; MALE; MIDDLE AGED; MORTALITY; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SEX DISTRIBUTION; SURVIVAL ANALYSIS;

EID: 77749270724     PISSN: 14714418     EISSN: 14751534     Source Type: Journal    
DOI: 10.4104/pcrj.2009.00048     Document Type: Article

References (31)

1. Alberg AJ, Samet JM. Epidemiology of lung cancer. Chest 2003;123(1 Suppl): 21S-49S. http://dx.doi.org/10.1378/chest.123.1-suppl. 21S
2. Tockman, MS Other host factors and lung cancer susceptibility. Samet, JM eds. Epidemiology of lung cancer 1994, 397-412 Marcel Dekker New York, NY.
3. Lange P, Nyboe J, Appleyard M, Jensen G, Schohr P. Ventilatory function and chronic mucus hypersecretion as predictors of death from lung cancer. Am Rev Respir Dis 1990;141:613-17.
4. US Department of Health, and Human Services (USDHHS). The health consequences of smoking: chronic obstructive lung disease; a report of the Surgeon General. 1984 US Government Printing Office Washington, DC.
5. Kennedy TC, Proudfoot SP, Franklin WA, et al. Cytopathological analysis of sputum in patients with airflow obstruction and significant smoking histories. Cancer Res 1996;56:4673-8.
6. Diez-Herranz A. COPD and lung cancer: practical implications. Arch Broncopneumol 2001;37(5):240-7.
7. Prindiville SA, Byers T, Hirsch FR, et al. Sputum cytological atypia as a predictor of incident lung cancer in a cohort of heavy smokers with airflow obstruction. Cancer Epidemiol, Biomarkers & Prev 2003;12:987-93.
8. Wasswu-Kintu S, Gan WQ, Man SF, Pare PD, Sin DD. Relationship between reduced forced expiratory volume in one second and the risk of lung cancer: a systematic review and meta-analysis. Thorax 2005;60:570-5. http://dx.doi.org/10.1136/thx.2004.037135
9. Brody JS, Spira A. State of the art. Chronic obstructive pulmonary disease, inflammation, and lung cancer. Proc Am Thorac Soc 2006;3:535-7. http://dx.doi.org/10.1513/pats.200603-089MS
10. Purdue MP, Gold L, Järvholm B, Alavanja MC, Ward MH, Vermeulen R. Impaired lung function and lung cancer incidence in a cohort of Swedish construction workers. Thorax 2007;62:51-6. http://dx.doi.org/10. 1136/thx.2006.064196
11. Proctor RN. Tobacco and the global lung cancer epidemic. Nat Rev Cancer 2001;1:82-6. http://dx.doi.org/10.1038/35094091
12. Spira A, Beane J, Shah V, et al. Effects of cigarette smoke on the human airway epithelial cell transcriptome. Proc Natl Acad Sci USA 2004;101:10143-8. http://dx.doi.org/10.1073/pnas.0401422101
13. Hubbard R, Venn A, Lewis S, Britton J. Lung cancer and cryptogenic fibrosing alveolitis. A population-based cohort study. Am J Respir Crit Care Med 2000;161:5-8.
14. Langman MJ, Cheng KK, Gilman EA, Lancashire RJ. Effect of anti-inflammatory drugs on overall risk of common cancer: case-control study in general practice research database. BMJ 2000;320:1642-6. http://dx.doi.org/10.1136/bmj.320.7250.1642
15. Pride NB, Soriano JB. Chronic obstructive pulmonary disease in the United Kingdom: trends in mortality, morbidity, and smoking. Curr Opin Pulm Med 2002;8:95-101.
16. Hansell A, Hollowell J, Nichols T, et al. Use of the General Practice Research Database (GPRD) for respiratory epidemiology: a comparison with the 4th Morbidity Survey in General Practice (MSGP4). Thorax 1999;54:413-19.
17. Nazareth I, King M, Haines A. Rangel L. Myers S. Accuracy of diagnosis on general practice computer system. BMJ 1993;307:32-4. http://dx.doi.org/ 10.1136/bmj.307.6895.32
18. Soriano JB, Maier WC, Egger P, et al. Recent trends of physician-diagnosed COPD in women and men in the UK. Thorax 2000;55:789-94. http://dx.doi.org/10.1136/thorax.55.9.789
19. Soriano JB, Vestbo J, Pride NB, Kiri V, Maier WC. Survival of COPD patients after regular use of fluticasone propionate and salmeterol in primary care in the UK. Eur Respir J 2002;20:819-25. http://dx.doi.org/10. 1183/09031936.02.00301302
20. Kiri VA, Bettoncelli G, Testi R, et al. Inhaled corticosteroids are more effective in COPD patients when used with LABA than with SABA. Respir Med 2005; 99:1115-24. http://dx.doi.org/10.1016/j.rmed. 2005.02.018
21. Kiri VA, Pride NB, Soriano JB, et al. Inhaled corticosteroids in chronic obstructive pulmonary disease: results from two observational designs free of immortal time bias. Am J Respir Crit Care Med 2005;172:460-4. http://dx.doi.org/10.1164/rccm.200502-210OC
22. Soriano JB, Kiri VA, Maier WC, Strachan D. Increasing prevalence of asthma in UK primary care during the 1990s. Int J Tuberc Lung Dis 2003;7:415-21.
23. Skillrud DM, Offord KP, Miller RD. Higher risk of lung cancer in chronic obstructive pulmonary disease. A prospective, matched, controlled study. Ann Intern Med 1986;105:503-07.
24. Tockman MS, Anthonisen NR, Wright EC, Donithan MG. Airways obstruction and the risk for lung cancer. Ann Intern Med 1987;106:512-18.
25. Cohen BH, Diamond EL, Graves CG, et al. A common familial component in lung cancer and chronic obstructive pulmonary disease. Lancet 1977;2:523-26. http://dx.doi.org/10.1016/S0140-6736(77) 90663-8
26. Chronic Obstructive Lung Disease, NF Voelkel & W MacNee Eds. BC Dekker Inc; Hamilton: 2002.
27. Kurishima K, Satoh H, Ishikawa H, et al. Lung cancer patients with chronic obstructive pulmonary disease. Oncol Rep 2001;8:63-5.
28. Nakayama M, Satoh H, Sekizawa K. Risk of cancers in COPD patients. Chest 2003;123:1775-6. http://dx.doi.org/10.1378/chest.123.5.1775- a
29. Mannino DM, Aguayo SM, Petty TL, Redd SC. Low lung function and incident lung cancer in the United States: data From the First National Health and Nutrition Examination Survey follow-up. Arch Intern Med 2003;163:1475-80.
30. Pauwels RA, Buist AS, Calverley PM, Jenkins CR, Hurd SS. Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) workshop summary. Am J Respir Crit Care Med 2001;163:1256-76.
31. Wilson DO, Weissfeld JL, Balkan A, et al. Association of Radiographic Emphysema and Airflow Obstruction with Lung Cancer. Am J Respir Crit Care Med 2008;178:738-44. http://dx.doi.org/10.1164/rccm.200803- 435OC